It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...

The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting antiretroviral treatment, as early as March or April 2026.

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...

JOHANNESBURG (AP) — South Africa's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a “groundbreaking” tool to fight the disease, but warned ...

By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...

With millions of South Africans affected by both HIV/AIDS and mental health challenges, leading experts have come together at ...

In response, the South African National Treasury allocated R750 million in emergency funding to prevent service interruptions ...

One in ten clinics in South Africa — across 22 health districts in six provinces — could start to hand out a twice-a-year anti-HIV jab as early as February if the country’s medicines regulator ...

UMZIMKHULU, South Africa (AP) — At a rural village in South Africa's KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for the one-hour ride ...